Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia
Top Cited Papers
- 7 January 2016
- journal article
- research article
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 374 (1), 13-22
- https://doi.org/10.1056/nejmoa1414838
Abstract
The ratio of soluble fms-like tyrosine kinase 1 (sFlt-1) to placental growth factor (PlGF) is elevated in pregnant women before the clinical onset of preeclampsia, but its predictive value in women with suspected preeclampsia is unclear.Keywords
This publication has 36 references indexed in Scilit:
- Pre-eclampsia part 1: current understanding of its pathophysiologyNature Reviews Nephrology, 2014
- Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysisBMJ, 2013
- Redefining Preeclampsia Using Placenta-Derived BiomarkersHypertension, 2013
- Saving Mothers’ Lives: reviewing maternal deaths to make motherhood safer: 2006–8: a reviewBritish Journal of Anaesthesia, 2011
- The Global Impact of Pre-eclampsia and EclampsiaSeminars in Perinatology, 2009
- Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort studyBMJ, 2009
- Epidemiology and causes of preterm birthThe Lancet, 2008
- Soluble Endoglin and Other Circulating Antiangiogenic Factors in PreeclampsiaThe New England Journal of Medicine, 2006
- Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJCI Insight, 2003
- The Interval between Pregnancies and the Risk of PreeclampsiaThe New England Journal of Medicine, 2002